Fragment‐Based Discovery of a Dual pan‐RET/VEGFR2 Kinase Inhibitor Optimized for Single‐Agent Polypharmacology

By  

ANGEWANDTE CHEMIE, Vol. 127, Iss. 30, 2015-07 ,pp. : 8841-8845

John Wiley & Sons Inc

Access to resources Recommend Favorite

Innenrücktitelbild: Fragment‐Based Discovery of a Dual pan‐RET/VEGFR2 Kinase Inhibitor Optimized for Single‐Agent Polypharmacology (Angew. Chem. 30/2015)

By  

ANGEWANDTE CHEMIE, Vol. 127, Iss. 30, 2015-07 ,pp. : 8973-8973

John Wiley & Sons Inc

Access to resources Recommend Favorite

Inside Back Cover: Fragment‐Based Discovery of a Dual pan‐RET/VEGFR2 Kinase Inhibitor Optimized for Single‐Agent Polypharmacology (Angew. Chem. Int. Ed. 30/2015)

By  

ANGEWANDTE CHEMIE INTERNATIONAL EDITION, Vol. 54, Iss. 30, 2015-07 ,pp. : 8847-8847

John Wiley & Sons Inc

Access to resources Recommend Favorite

Fragment‐Based Drug Discovery. Edited by Steven Howard and Chris Abell

By  

CHEMMEDCHEM, Vol. 10, Iss. 12, 2015-12 ,pp. : 2112-2113

John Wiley & Sons Inc

Access to resources Recommend Favorite

Discovery of Novel Scaffolds for Rho Kinase 2 Inhibitor Through TRFRET- Based High Throughput Screening Assay

By  

Combinatorial Chemistry & High Throughput Screening, Vol. 16, Iss. 1, 2013-01 ,pp. : 37-46

Bentham Science Publishers

Access to resources Recommend Favorite